Flotek Industries
FTK
27.62
-0.44
-1.57%
Flotek Industries
US · FTK
#3236 by market cap
27.62
-0.44
-1.57%
Live - 5344 symbols - heartbeat 164s ago
· 2026-10-08 10:10
Pre-market
28.62
+2.00%
After-hours
28.06
0.00%
- Market cap
- 1.00B
- P/E (TTM)i
- 27.35
- P/Bi
- 7.74
- EPSi
- 0.84
- Div yieldi
- 0.00%
- 52W posi
- 54%
Reader sentiment
Are you bullish or bearish on FTK?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.56, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +26.86% YoY
Margins
- Gross margin
- 25.22%
- Operating margin
- 11.86%
- Net margin
- 12.87%
Key ratios & quality
- Enterprise valuei
- 1.04B
- Altman Z-Scorei
- 5.56
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 177.77M | 119.35M | 53.14M | 43.27M | 136.09M | 188.06M | 187.03M | 237.26M |
| Gross profit | 168.56M | 110.89M | -28.67M | 3.26M | -6.70M | 24.26M | 39.39M | 59.83M |
| Selling & admin expenses | 31.47M | 27.98M | 22.76M | 20.17M | 27.12M | 27.83M | 24.71M | 28.05M |
| Research & development | 10.36M | 8.86M | 7.21M | 5.54M | 4.44M | 2.49M | 1.71M | 1.82M |
| Operating profit | -33.07M | -74.05M | -62.06M | -23.46M | -39.00M | -6.78M | 12.07M | 28.13M |
| Pretax profit | -80.66M | -75.81M | -142.63M | -30.57M | -42.33M | 24.86M | 11.15M | 19.66M |
| Tax | -7.22M | 262.00K | -6.18M | -40.00K | -22.00K | 149.00K | 649.00K | -10.87M |
| Net profit | -70.70M | -33.92M | -136.45M | -30.53M | -42.31M | 24.71M | 10.50M | 30.53M |
| Basic EPS | -7 | -3 | -12 | -3 | -3 | 1 | 0 | 1 |
| Diluted EPS | -7.26 | -3.42 | -12.00 | -2.52 | -3.41 | -0.10 | 0.34 | 0.84 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 55.36M | 58.35M | 56.03M | 67.52M | 70.05M | 99.37M |
| Gross profit | 12.45M | 14.41M | 17.78M | 15.19M | 15.54M | 23.78M |
| Selling & admin expenses | 6.28M | 6.80M | 7.38M | 7.58M | 6.93M | 7.74M |
| Research & development | 355.00K | 455.00K | 549.00K | 463.00K | 396.00K | 497.00K |
| Operating profit | 5.56M | 6.78M | 9.27M | 6.52M | 7.59M | 14.89M |
| Pretax profit | 5.44M | 1.79M | 7.74M | 4.68M | 6.27M | 13.53M |
| Tax | 64.00K | 17.00K | -12.61M | 1.66M | 1.61M | 3.58M |
| Net profit | 5.38M | 1.77M | 20.36M | 3.03M | 4.66M | 9.95M |
| Basic EPS | 0 | 0 | 1 | 0 | 0 | 0 |
| Diluted EPS | 0.17 | 0.05 | 0.53 | 0.08 | 0.12 | 0.26 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 194.78M | 153.91M | 66.46M | 42.60M | 80.07M | 76.45M | 96.46M | 110.78M |
| Cash & ST investments | 3.04M | 100.58M | 38.66M | 11.53M | 12.29M | 5.85M | 4.40M | 5.73M |
| Inventory | 27.29M | 23.21M | 11.84M | 9.45M | 15.72M | 12.84M | 13.30M | 10.63M |
| Total assets | 285.88M | 230.60M | 86.21M | 50.24M | 164.81M | 157.51M | 170.80M | 220.05M |
| Total current liabilities | 84.26M | 41.32M | 28.86M | 18.78M | 151.37M | 47.78M | 50.37M | 61.58M |
| Short-term debt | 49.73M | 541.00K | 4.74M | 2.08M | 108.79M | 10.14M | 6.34M | 4.74M |
| Long-term debt | -- | -- | 1.62M | 3.35M | 2.74M | 60.00K | -- | 39.58M |
| Total liabilities | 84,259,000.00 | 58,571,000.00 | 39,039,000.00 | 30,052,000.00 | 162,214,000.00 | 55,553,000.00 | 56,896,000.00 | 106,991,000.00 |
| Total equity | 201.62M | 172.03M | 47.17M | 20.19M | 2.60M | 101.96M | 113.90M | 113.06M |
| Retained earnings | -107.57M | -142.24M | -278.69M | -309.21M | -351.52M | -326.81M | -316.31M | -285.78M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 97.35M | 86.83M | 100.02M | 110.78M | 125.79M | 167.54M |
| Cash & ST investments | 6.25M | 5.03M | 4.60M | 5.73M | 5.68M | 4.40M |
| Inventory | 13.69M | 12.30M | 13.23M | 10.63M | 14.30M | 26.63M |
| Total assets | 170.24M | 172.24M | 212.69M | 220.05M | 231.84M | 268.04M |
| Total current liabilities | 44.40M | 54.68M | 56.48M | 61.58M | 68.73M | 94.15M |
| Short-term debt | 1.33M | 6.39M | 8.03M | 4.74M | 6.11M | 11.88M |
| Long-term debt | -- | 39.54M | 39.56M | 39.58M | 39.61M | 39.63M |
| Total liabilities | 50,533,000.00 | 100,393,000.00 | 102,189,000.00 | 106,991,000.00 | 113,668,000.00 | 138,823,000.00 |
| Total equity | 119.70M | 71.85M | 110.50M | 113.06M | 118.18M | 129.21M |
| Retained earnings | -310.93M | -309.16M | -288.81M | -285.78M | -281.12M | -271.16M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -19.52M | -4.87M | -47.84M | -25.84M | -44.63M | -11.30M | 3.36M | 7.20M |
| Depreciation & amortization | 9.22M | 8.47M | 3.41M | 1.01M | 734.00K | 734.00K | 891.00K | 1.84M |
| Free cash flow | -24.68M | -7.89M | -49.27M | -25.88M | -45.05M | -12.38M | 1.42M | 5.22M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 168.00K | -212.00K | 462.00K | 80.00K | 133.00K | -- | -- | -- |
| Ending cash balance | 3.04M | 101.24M | 39.32M | 13.32M | 12.39M | 5.95M | 4.51M | 5.84M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 7.31M | -4.49M | -1.87M | 6.25M | 21.00K | -6.60M |
| Depreciation & amortization | 252.00K | 374.00K | 581.00K | 629.00K | 631.00K | 664.00K |
| Free cash flow | 6.72M | -5.20M | -2.25M | 5.96M | -981.00K | -6.84M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 6.36M | 5.03M | 4.60M | 5.84M | 5.78M | 4.40M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -30.15 | -17.22 | -123.79 | -90.63 | -371.29 | 47.27 | 9.73 | 26.90 |
| ROA %i | -22.85 | -12.47 | -85.80 | -44.74 | -39.34 | 15.33 | 6.40 | 15.62 |
| ROIC %i | -24.89 | -13.18 | -107.85 | -63.81 | -45.31 | 22.77 | 9.35 | 23.20 |
| 5-year avg ROE %i | -8.44 | -15.93 | -39.93 | -54.67 | -126.95 | -111.46 | -105.88 | -75.60 |
| EBIT margin %i | -43.76 | -62.77 | -268.28 | -70.46 | -25.92 | 14.74 | 6.55 | 9.94 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | 0.76 | 2.20 |
| Current ratioi | 2.31 | 3.72 | 2.30 | 2.27 | 0.53 | 1.60 | 1.92 | 1.80 |
| Quick ratioi | 0.51 | 2.83 | 1.76 | 1.32 | 0.40 | 1.25 | 1.59 | 1.57 |
| Debt / assetsi | 17.40 | 7.66 | 17.17 | 26.40 | 72.56 | 11.35 | 7.52 | 22.79 |
| LT debt / equityi | -- | 9.96 | 21.33 | 55.39 | 415.99 | 7.59 | 5.72 | 40.17 |
| Interest coveragei | -27.14 | -37.11 | -2,376.15 | -390.87 | -5.00 | 9.70 | 11.18 | 5.99 |
| Revenue CAGR (3Y) %i | -13.00 | -14.09 | -39.76 | -37.56 | 4.47 | 52.39 | 62.90 | 20.36 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 12.80 | 15.85 | 29.10 | 26.90 | 25.06 | 37.80 |
| ROA %i | 8.78 | 8.60 | 17.11 | 15.62 | 14.83 | 17.26 |
| ROIC %i | 12.59 | 12.87 | 24.12 | 23.20 | 22.16 | 26.64 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.84 | 7.61 | 10.24 | 9.94 | 10.13 | 12.86 |
| FCF / sales %i | 2.18 | 1.09 | -- | 2.20 | -- | -- |
| Current ratioi | 2.19 | 1.59 | 1.77 | 1.80 | 1.83 | 1.78 |
| Quick ratioi | 1.80 | 1.30 | 1.49 | 1.57 | 1.58 | 1.46 |
| Debt / assetsi | 4.37 | 30.25 | 25.27 | 22.79 | 22.02 | 21.08 |
| LT debt / equityi | 5.11 | 63.63 | 41.37 | 40.17 | 38.03 | 34.53 |
| Interest coveragei | 15.14 | 9.47 | 8.02 | 5.99 | 5.06 | 6.94 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Chemistry Technologies is the largest reported line at 80.70% of revenue, across 2 reported segments.
- The next-largest line, Data Analytics, is a distant second at 19.30% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Chemistry Technologies80.70%
Data Analytics19.30%
Quote time 2026-10-08 10:10:59 · For reference only, not investment advice and not tailored to your situation.